Gates MRI looks to Phase 3 TB vaccine trial with epidemiology study
Rachel Arthur
April 5, 2022, 3:15 p.m.
The Bill & Melinda Gates Medical Research Institute (MRI) is conducting a TB epidemiology study: setting the stage for a Phase 3 efficacy trial for its investigational TB vaccine.